Skip to main content
OpenTrials
Completed

NCT Number: NCT06788782

Analysis of Candida-Associated Osteoarticular Infections: Multicenter Turkish Data

The aim of this observational study was to retrospectively analyze the osteoarticular infections caused by Candida spp. in adult patients in Turkey during the last decade and to determine the distribution of causative agents, demographic data, risk factors, clinical, radiological and laboratory findings. It was also aimed to compare treated and untreated cases and to reveal the factors influencing the success of treatment.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Kocaeli University

Kocaeli, Turkey (Türkiye)

About this study

Osteoarticular infections caused by Candida species can cause serious morbidity if not diagnosed and treated early. There are two large reviews of osteomyelitis and arthritis cases in the literature, and other data on the disease are based on case reports or small case series. Treatment recommendations for rare infections, such as Candida-associated osteomyelitis, are based on small case series and case reports from randomized clinical trials designed on other clinical forms of the disease. Amphotericin B is the most commonly used treatment of choice; however, recent reports suggest that fluconazole or echinocandin may be used. There are case reports in Turkey, but no multicenter study data have been reported.

The aim of this retrospective observational study was to investigate the osteoarticular infections caused by Candida spp. in Turkey, to reveal the distribution of causative agents, demographic data, risk factors, clinical, radiologic and laboratory findings, and to contribute to the literature with the data to be obtained at the end of the study in the management of these infections by comparing successful and unsuccessful cases in treatment.

It was planned to share the Excel file prepared by the principal investigator containing the data to be collected via e-mail, and to evaluate all the data after collection via e-mail.

Statistical evaluation will be performed using IBM SPSS (version 29.0; IBM Corp., Armonk, NY, USA). Chi-square and Fisher's exact tests will be used to compare the categorical variables. The conformity of measurement variables to normal distribution will be examined by Kolmogorov-Smirnov test. Descriptive analyses will be presented using the mean, standard deviation, median, and minimum-maximum values. Risk factors for treatment failure or side effects will be evaluated using the Mann-Whitney U test or Student's t-test. Treatment failure will be considered the dependent variable and will be analyzed using univariate logistic regression with other variables. A P value < 0.05 will be considered significant. In a stepwise approach, the variables found to be significant in the univariate logistic regression test will be analyzed using multivariate logistic regression analysis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients over 18 years of age
  • Cases of osteomyelitis, septic arthritis and spondylodiscitis due to Candida spp.
  • Deep tissue culture, joint fluid or bone tissue growth is required. In addition, patients with compatible clinical and radiographic findings will be enrolled.

Exclusion criteria

  • Pediatric patients
  • Patients with Candida spp. growth in superficial tissue culture will not be part of the study.

Treatment and study plan

Primary outcomes

  1. The aim of this study was to evaluate the clinical findings of patients with Candida osteoarticular infection.

    Time frame: Data will be collected retrospectively by reviewing the files of cases diagnosed in the last ten years (between 1 January 2014 and 1 December 2024) (last 10 years). Review of files and enrollment of cases into the study started on 5 December 2024.

    Description This outcome measure aims to assess the findings of cases of Candida osteoarticular infection. Four specific findings will be inquired about.

    Pain, swelling, redness, and purulent discharge.

    Measurement Tool/Method: Clinical findings will be assessed using a patient chart review form.

    Unit of Measure: Each clinical finding will be expressed as a percentage.

  2. Microbiological Characteristics of Candida species

    Time frame: Data will be collected retrospectively by reviewing the files of cases diagnosed in the last ten years (between 1 January 2014 and 1 December 2024) (last 10 years). Review of files and enrollment of cases into the study started on 5 December 2024.

    Description: This outcome measure aims to describe the microbiological profiles of Candida osteoarticular infections

    Measure Description Fungal culture results by VITEC-2 or MALDI-TOF will be evaluated.

    Unit of measurement: Percentage of Candida species detected.

Secondary outcomes

  1. Treatment success of Candida osteoarticular infections

    Time frame: Data will be collected retrospectively by reviewing the files of cases diagnosed in the last ten years (between 1 January 2014 and 1 December 2024) (last 10 years). Review of files and enrollment of cases into the study started on 5 December 2024.

    This outcome measure investigates the success rate of treatment strategies for Candida osteoarticular infections. Treatment success is defined as resolution of symptoms, eradication of infection, and no recurrence within 6 months after completing therapy.

    Measurement Tool/Method: Success will be assessed based on follow-up clinical evaluations and microbiological clearance confirmed by repeat cultures.

    Unit of Measure: Percentage of participants achieving treatment success.

Other outcomes

  1. Factors affecting treatment success

    Time frame: Data will be collected retrospectively by reviewing the files of cases diagnosed in the last ten years (between January 1, 2014, and December 1, 2024) (the last 10 years). The review of files and the enrollment of cases into the study by invitation began

    Factors affecting treatment success The evaluation will be conducted using the logistic regression method. The results will be presented as an odds ratio.

Sponsors and collaborators

Lead sponsor

Kocaeli University

Other

Collaborators

  • Istinye University

Registry information

Official study title

Retrospective Analysis of Candida-associated Osteoarticular Infections: Multicenter Data From Turkey

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jan 23, 2025
Registry last updated
Apr 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.